Equity Capital Markets

Company · CIK 899923

MYRIAD GENETICS INC

CIK899923 (SEC EDGAR)
Industry (SIC)2835 — In Vitro & In Vivo Diagnostic Substances
Incorporated inDE
Business addressUT
ListedMYGN (Nasdaq)
First annual or quarterly report1996-11-08

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-293681
ShelfEffective
 2026-02-242026-03-042
333-275396
ShelfEffective
 2023-11-082023-11-133
333-226492
ShelfEffective
 2018-08-012018-08-011
333-123914
ShelfEffective
 2005-04-072007-02-093

Filings

11
FiledFilingRegistrationAccession
2026-03-04EFFECTDeclared effective 333-2936819999999995-26-000727
2026-02-24S-3Shelf registered 333-2936810000899923-26-000020
2023-11-13424B5Shelf takedown 333-2753960000899923-23-000104
2023-11-08424B5Shelf takedown 333-2753960000899923-23-000099
2023-11-08S-3ASRShelf registered 333-2753960000899923-23-000097
2018-08-01S-3ASRShelf registered 333-2264920001193125-18-234932
2007-02-09424B5Shelf takedown 333-1239140001193125-07-025669
2005-11-04424B5Shelf takedown 333-1239140001193125-05-215986
2005-04-07S-3Shelf registered 333-1239140001193125-05-071544
2004-06-04424B5Shelf takedown 333-731240001193125-04-098826
2002-11-22424B5Shelf takedown 333-731240000927016-02-005666

All filings of this company · CSV